These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 5055035)

  • 21. [Mechanisms of experimental hematogenous metastasis and its dependence on the reactive defense in the host organism].
    Arnold W; Graffi A
    Z Exp Chir; 1974; 7(4):216-27. PubMed ID: 4440031
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antibodies against cells of methylcholanthrene sarcoma in the blood of intact mice].
    Fedorovskaia MI; Vetrova EP; Umanskii IuA
    Biull Eksp Biol Med; 1973 Jul; 76(7):78-80. PubMed ID: 4774443
    [No Abstract]   [Full Text] [Related]  

  • 23. Influence of BCG infection on growth of 3-methylcholanthrene-induced rat sarcomas.
    Baldwin RW; Pimm MV
    Rev Eur Etud Clin Biol; 1971 Nov; 16(9):875-81. PubMed ID: 4945964
    [No Abstract]   [Full Text] [Related]  

  • 24. Association between immunoglobulin and macrophages in primary methylcholanthrene-induced sarcomas.
    Wood GW; Tilzer SA; Gollahon KA; Lindsay JM
    Cancer Res; 1979 Nov; 39(11):4588-93. PubMed ID: 498089
    [No Abstract]   [Full Text] [Related]  

  • 25. A preliminary investigation into the role of immunity in modifying the blood- borne spread of chemically induced rat sarcomas.
    Proctor JW; Rudenstam CM; Alexander P
    J Natl Cancer Inst; 1974 Dec; 53(6):1671-6. PubMed ID: 4373575
    [No Abstract]   [Full Text] [Related]  

  • 26. [Spontaneous metastasising of a methylcholanthrene induced sarcoma in animals with intact respective reduced immune reactivity].
    Boeryd B; Hagmar B; Suurküla M
    Nord Med; 1970 Nov; 84(45):1440. PubMed ID: 5481053
    [No Abstract]   [Full Text] [Related]  

  • 27. Antigenicity of cells derived from mouse prostate cells after malignant transformation in vitro by carcinogenic hydrocarbons.
    Mondal S; Iype PT; Griesbach LM; Heidelberger C
    Cancer Res; 1970 Jun; 30(6):1593-7. PubMed ID: 5457933
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunodepression as a factor during 3-methylcholanthrene carcinogenesis and subsequent tumour growth in mice.
    Rees JA; Symes MO
    Int J Cancer; 1973 Jan; 11(1):202-11. PubMed ID: 4151450
    [No Abstract]   [Full Text] [Related]  

  • 29. In vitro carcinogenesis studies on mouse fibroblast cells.
    Lapis K; Ferencz G; Szende B; Kovalszky I; Jeney A
    Acta Biol Acad Sci Hung; 1977; 28(3):247-57. PubMed ID: 615388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunologic properties of methylcholanthrene-induced sarcomas of neonatally thymectomized mice.
    Nomoto K; Takeya K
    J Natl Cancer Inst; 1969 Mar; 42(3):445-53. PubMed ID: 5779635
    [No Abstract]   [Full Text] [Related]  

  • 31. Thymocytolytic autoantibodies elicited by immunization of mice with chemically-induced sarcoma and leukemia cells.
    Merino F
    Acta Cient Venez; 1982; 33(5):402-5. PubMed ID: 6985343
    [No Abstract]   [Full Text] [Related]  

  • 32. Cellular reactions to methylcholanthrene-induced sarcomas transplanted to isogenic mice.
    Rosenau W; Moon HD
    Lab Invest; 1966 Jul; 15(7):1212-24. PubMed ID: 5947068
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on the basis for diversity and time of appearance of antigens in chemically induced tumors.
    Basombrío MA; Prehn RT
    Natl Cancer Inst Monogr; 1972 Dec; 35():117-24. PubMed ID: 4121493
    [No Abstract]   [Full Text] [Related]  

  • 34. [Kinetics of populations of theta+ and theta- cells in the lymph nodes of KR/j mice during methylcholanthrene carcinogenesis].
    Iudin VM; Fedorovskaia MI; Umanskiĭ IuA
    Vopr Onkol; 1976; 22(3):54-60. PubMed ID: 1084623
    [No Abstract]   [Full Text] [Related]  

  • 35. Cancer and the immune response.
    Prehn RT
    Proc Inst Med Chic; 1973; 29(10):339-45. PubMed ID: 4742681
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunogenicity of methylcholanthrene-induced tumors tested by draining lymph node assay in syngeneic rats.
    Ryzewska AG; Rybicka M; Kania A; Dabrowski M
    Neoplasma; 1980; 27(5):533-42. PubMed ID: 7231610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of the induction of contrasuppression by antisera against tumor-associated surface antigens on methylcholanthrene-induced sarcomas.
    Flood PM; DeLeo AB; Old LJ; Gershon RK
    Haematol Blood Transfus; 1983; 28():486-8. PubMed ID: 6222948
    [No Abstract]   [Full Text] [Related]  

  • 38. Simultaneous decrease of tumor-specific antigenicity and "hybrid effect" in a murine methylcholanthrene-induced sarcoma.
    Oth D; Donner M; Burg C
    Transplantation; 1969 Nov; 8(5):742-5. PubMed ID: 5403331
    [No Abstract]   [Full Text] [Related]  

  • 39. Syngeneic monoclonal antibodies to a methylcholanthrene-induced mouse sarcoma.
    Lennox E; Cohn J; Lowe T
    Transplant Proc; 1980 Mar; 12(1):95-8. PubMed ID: 7368297
    [No Abstract]   [Full Text] [Related]  

  • 40. The autoimmune nature of cancer.
    Prehn RT; Prehn LM
    Cancer Res; 1987 Feb; 47(4):927-32. PubMed ID: 3542202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.